(Q37616712)

21 August 2017

A pharmacogenetic versus a clinical algorithm for warfarin dosing (English)

1 reference

21 August 2017

1 reference

Patrice Delafontaine

21

0 references

Robert D McBane

object named as

Robert B McBane

10

0 references

Robert Califf

30

object named as

Robert M Califf

1 reference

21 August 2017

27

Jonathan L Halperin

1 reference

21 August 2017

22

Robert J Desnick

1 reference

21 August 2017

15

Margaret C Fang

1 reference

21 August 2017

Stephen E Kimmel

1

1 reference

21 August 2017

Benjamin French

2

1 reference

21 August 2017

Scott E Kasner

3

1 reference

21 August 2017

Julie A Johnson

4

1 reference

21 August 2017

Jeffrey L Anderson

5

1 reference

21 August 2017

Brian F Gage

6

1 reference

21 August 2017

Yves D Rosenberg

7

1 reference

21 August 2017

Charles S Eby

8

1 reference

21 August 2017

Rosemary A Madigan

9

1 reference

21 August 2017

Sherif Z Abdel-Rahman

11

1 reference

21 August 2017

Scott M Stevens

12

1 reference

21 August 2017

Steven Yale

13

1 reference

21 August 2017

Emile R Mohler

14

1 reference

21 August 2017

Vinay Shah

16

1 reference

21 August 2017

Richard B Horenstein

17

1 reference

21 August 2017

Nita A Limdi

18

1 reference

21 August 2017

James A S Muldowney

19

1 reference

21 August 2017

Jaspal Gujral

20

1 reference

21 August 2017

Thomas L Ortel

23

1 reference

21 August 2017

Henny H Billett

24

1 reference

21 August 2017

Robert C Pendleton

25

1 reference

21 August 2017

Nancy L Geller

26

1 reference

21 August 2017

Samuel Z Goldhaber

28

1 reference

21 August 2017

Michael D Caldwell

29

1 reference

21 August 2017

Jonas H Ellenberg

31

1 reference

21 August 2017

COAG Investigators

32

1 reference

21 August 2017

language of work or name

English

0 references

publication date

19 November 2013

1 reference

The New England Journal of Medicine

21 August 2017

1 reference

21 August 2017

369

1 reference

21 August 2017

24

1 reference

21 August 2017

2283-2293

1 reference

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality after rheumatic valve replacement: a randomized and controlled trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

The future of warfarin pharmacogenetics in under-represented minority groups

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Genetics and cardiovascular disease: a policy statement from the American Heart Association.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Prospective alpha allocation in the clarification of optimal anticoagulation through genetics (COAG) trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Debating clinical utility

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Integration of genetic, clinical, and INR data to refine warfarin dosing

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Estimation of the warfarin dose with clinical and pharmacogenetic data

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Idraparinux versus standard therapy for venous thromboembolic disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

A method to determine the optimal intensity of oral anticoagulant therapy.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

A randomized controlled trial of genotype-based Coumadin initiation.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

The long and winding road to warfarin pharmacogenetic testing.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Pharmacogenetics--tailoring treatment for the outliers

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942158

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24251361

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1310669

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24251361

1 reference